Combined proton-photon therapy for non-small cell lung cancer.

Florian AmstutzSilvia FabianoLouise MarcDamien Charles WeberAntony John LomaxJan UnkelbachYe Zhang

Published in: Medical physics (2022)

Optimally combined proton-photon plans improve treatment plan quality compared to IMRT only, potentially reducing the risk of toxicity while also allowing to potentially increase accessibility to proton therapy for NSCLC patients.

Keyphrases

end stage renal disease
small cell lung cancer
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
living cells
prognostic factors
patient reported outcomes
health insurance
advanced non small cell lung cancer
electron transfer
quality improvement